GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **1476 - 1500** of **4050** in total

« First

‹ Prev

…

56

57

58

59

60

61

62

63

64

…

Next ›

Last »
Antibody	Patient ▲	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU)
IgA	Patient 2	24	mild	G92823JK	345
IgA	Patient 2	24	mild	G93351GM	672
IgA	Patient 2	24	mild	G94435QH	343
IgA	Patient 2	24	mild	G94576MN	502
IgA	Patient 2	24	mild	G96557TJ	408
IgA	Patient 2	24	mild	G96865DJ	357
IgA	Patient 2	24	mild	G96881BQ	298
IgA	Patient 2	24	mild	G98068PA	484
IgA	Patient 2	24	mild	G98240FC	441
IgA	Patient 2	24	mild	G99603GB	487
IgG	Patient 2	15	mild	G00048MO	32
IgG	Patient 2	15	mild	G00051MO	27
IgG	Patient 2	15	mild	G00052MO	33
IgG	Patient 2	15	mild	G00053MO	30
IgG	Patient 2	15	mild	G00054MO	35
IgG	Patient 2	15	mild	G00057MO	115
IgG	Patient 2	15	mild	G00065MO	57
IgG	Patient 2	15	mild	G00066MO	185
IgG	Patient 2	15	mild	G00068MO	31
IgG	Patient 2	15	mild	G02557XE	26
IgG	Patient 2	15	mild	G02670IJ	32
IgG	Patient 2	15	mild	G03499BP	45
IgG	Patient 2	15	mild	G07483YN	31
IgG	Patient 2	15	mild	G08340FW	6474
IgG	Patient 2	15	mild	G08520NM	36